118th Congress Health
H.R. 2666: Medicaid VBPs for Patients Act
Reported
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)
The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.
Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.
Read the full summary
The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Jake Auchincloss D-MAOriginal
- Anna Eshoo D-CAOriginal
- John Joyce R-PAOriginal
- Mariannette Miller-Meeks R-IAOriginal
- Scott Peters D-CAOriginal
- Dan Crenshaw R-TX
- Eric Swalwell D-CA
- Gus Bilirakis R-FL
- Neal Dunn R-FL
- Troy Balderson R-OH
- Dean Phillips D-MN
- Ami Bera D-CA
- Ted Lieu D-CA
- Mike Thompson D-CA
- Mikie Sherrill D-NJ
- Chrissy Houlahan D-PA
- Earl Carter R-GA
- Josh Gottheimer D-NJ
- Troy Carter D-LA
- A. Ferguson R-GA
- Jared Huffman D-CA
- Kevin Mullin D-CA
- Brittany Pettersen D-CO
- Josh Harder D-CA
- Larry Bucshon R-IN
- Donald Davis D-NC
- Michael Burgess R-TX
- Glenn Ivey D-MD
- Mike Kelly R-PA
- Austin Scott R-GA
- Clarence Owens R-UT
- John Moolenaar R-MI
- Daniel Meuser R-PA
- Juan Ciscomani R-AZ
- Yadira Caraveo D-CO
- Jefferson Van Drew R-NJ
- Jeff Duncan R-SC
- Nicole Malliotakis R-NY
- Michelle Steel R-CA
- Katherine Cammack R-FL
- Beth Van Duyne R-TX
- Marilyn Strickland D-WA
Who scored on this bill
- 1Brett Guthrie SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone, reported, discharged5 events+56
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Brett Guthrie
History
- Introduced in the House by Brett Guthrie.
Show the full action history (12 actions)
- Committee on Ways and Means discharged.
- Placed on the Union Calendar, Calendar No. 768.
- Referred to the Subcommittee on Work and Welfare.
- Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.
- House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
- Committee Consideration and Mark-up Session Held.
- Ordered to be Reported (Amended) by the Yeas and Nays: 31 - 19.
- Subcommittee Consideration and Mark-up Session Held.
- Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 11 .
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.